The Cochrane database of systematic reviews

Using Competitions to Help People Quit Smoking

Updated

Abstract

Twenty studies were included in this review, with a total of 11,495 participants.

  • Performance-based eligibility interventions did not show evidence of effectiveness for long-term smoking cessation (risk ratio 1.16, 95% CI 0.77 to 1.74).
  • No beneficial effects on long-term quit rates were found in trials using performance-based rewards.
  • Population-level Quit & Win studies indicated higher cessation rates (4% to 16.9%) compared to control groups, but lacked rigorous randomized designs.
  • Fewer than one in 500 smokers may quit due to competition-based incentives.
  • Overall evidence quality for smoking cessation competitions is rated as 'very low' due to high bias risk and methodological issues.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

TRF: none known. JHB: none known. RP: none known. NL is employed by the University of Oxford to work as a Managing Editor for the Cochrane Tobacco Addiction Review Group. Core infrastructure funding for the Cochrane Tobacco Addiction Group is provided by the NIHR to the University of Oxford. She was a co‐applicant and collaborator on a research grant awarded by the NIHR HTA programme (09/110/01), investigating the use of pre‐quit nicotine patches for smoking cessation. The excess treatment provided for this research were nicotine patches, supplied free of charge by GlaxoSmithKline (GSK). However, GSK had no further involvement in the research, and this had no impact on the reported work. This trial was completed in 2016.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free